The effect on diurnal intraocular pressure of the fixed combination of latanoprost 0.005% and timolol 0.5% in patients with ocular hypertension

Acta Ophthalmologica Scandinavica

Volumn 79, Issue 2, 2001, Pages 125-128

  Larsson, L I ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Fixed combination; Glaucoma; Intraocular pressure; Latanoprost; Ocular hypertension; Timolol

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; CHOLINERGIC RECEPTOR STIMULATING AGENT; ESTER DERIVATIVE; EYE DROPS; LATANOPROST; PLACEBO; PROSTAGLANDIN F2 ALPHA; TIMOLOL;

ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG POTENTIATION; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; PRESSURE MEASUREMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICS;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; CIRCADIAN RHYTHM; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; PROSTAGLANDINS F, SYNTHETIC; TIMOLOL;

EID: 0035088683     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.2001.079002125.x     Document Type: Article

References (20)

1. Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol
2. Effects on intraocular pressure and side effects of 0.005% latanoprost once daily, evening and morning. A comparison with timolol
3. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma. A six-month, masked, multicenter trial in the United States
4. Latanoprost, a prostaglandin analog, for glaucoma treatment. Efficacy and safety after one year of treatment in 198 patients
5. Comparison of two fixed combinations of latanoprost and timolol in open-angle glaucoma
6. 2α-isopropyl ester analogues for glaucoma treatment
7. Ocular hypertensive effect of PhXA41 in patients with ocular hypertension of primary open-angle glaucoma
8. Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution
9. 2α-1-isopropyl ester to timolol in glaucoma patients
10. A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study
11. Compliance in patients prescribed eyedrops for glaucoma
12. 2α-analogue, and timolol in patients with elevated intraocular pressure
13. 2α analogue
14. 2α analogue, on aqueous humor dynamics in human eyes
15. Long-term evaluation of timolol
16. 2α-isopropylester to timolol in patients with open angle glaucoma. A randomized, masked placebo-controlled study
17. A six month randomized double-masked study comparing latanoprost to timolol in open angle glaucoma and ocular hypertension
18. Latanoprost - Two years experience of its use in the United Kingdom
19. Compliance with medical treatments of glaucoma
20. 2α analogue, after topical application in normal and ocular hypertensive human eyes